W, V., J, F., MF, B., E, C., F, V. L., L, N., . . . JM, T. (2024). The novel family of Warbicin® compounds inhibits glucose uptake both in yeast and human cells and restrains cancer cell proliferation. Frontiers in oncology, 14, 1411983. https://doi.org/10.3389/fonc.2024.1411983
Chicago Style (17th ed.) CitationW, Vanthienen, et al. "The Novel Family of Warbicin® Compounds Inhibits Glucose Uptake Both in Yeast and Human Cells and Restrains Cancer Cell Proliferation." Frontiers in Oncology 14 (2024): 1411983. https://doi.org/10.3389/fonc.2024.1411983.
MLA (9th ed.) CitationW, Vanthienen, et al. "The Novel Family of Warbicin® Compounds Inhibits Glucose Uptake Both in Yeast and Human Cells and Restrains Cancer Cell Proliferation." Frontiers in Oncology, vol. 14, 2024, p. 1411983, https://doi.org/10.3389/fonc.2024.1411983.
